GE DINAMAP ProCare 100 - Factory Default Settings; NELLCOR Patents; Masimo Spo; Measurement Range

Revision C DINAMAP
®
ProCare Monitor Service Manual A-7
2009381-001
Technical Specifications: Specifications
Power Dissipation Infrared: 22.5 mW (max)
Red: 30 mW (max)
Factory Default Settings
SpO
2
(%) HIGH Alarm Limit: 100
SpO
2
(%) LOW Alarm Limit: 90
Response Mode 2 (for Mode 2: Fast Response)
SatSeconds™ 0
NELLCOR
®
Patents
US Patent No. 4,802,486; 4,869,254; 4,928,692; 4,934,372; 5,078,136; 5,485,847;
5,743,263; 5,865,736; 6,035,223; 6,298,252; 6,463,310; 6,591,123; 6,675,031;
6,708,049; 6,801,797; Re. 35,122 and foreign equivalents.
Masimo SpO
2
Measurement Range
SpO
2
1 to 100%
Pulse Rate 25 to 240 beats/min
Perfusion Range 0.02 to 20%
Accuracy and Motion Tolerance
Saturation
Without Motion - Adult/Ped* 70 to 100% ±2 digits
Without Motion - Neonate* 70 to 100% ±3 digits
With Motion - Adult/Ped/Neo** †70 to 100% ±3 digits
Low Perfusion‡ 70 to 100% ±2 digits
0 to 69% unspecified
Pulse Rate
Without Motion 25 to 240 beats/min ±3 digits
With Motion normal physiologic range
25 to 240 beats/min ±5 digits
* The Masimo SET
®
SpO
2
parameter with LNOP-Adt sensors has been validated for no motion accuracy in human
blood studies on healthy adult volunteers in induced hypoxia studies in the range of 70-100% SpO
2
against a
laboratory co-oximeter and ECG monitor. This variation equals plus or minus one standard deviation. Plus or
minus one standard deviation encompasses 68% of the population.
**The Masimo SET
®
SpO
2
parameter with LNOP-Adt sensors has been validated for motion accuracy in
human blood studies on healthy adult volunteers in induced hypoxia studies while performing rubbing and
tapping motions at 2 to 4 Hz at an amplitude of 1 to 2 cm and a nonrepetitive motion between 1 to 5 Hz at
an amplitude of 2 to 3 cm in induced hypoxia studies in the range of 70-100% SpO2 against a laboratory
co-oximeter and ECG monitor. This variation equals plus or minus one standard deviation. Plus or minus one
standard deviation encompasses 68% of the population.
†The Masimo SET
®
SpO
2
parameter with LNOP-Neo Pt sensors has been validated for neonatal motion
accuracy in human blood studies on neonates while moving the neonate’s foot at 2 to 4 cm against a
laboratory co-oximeter and ECG monitor. This variation equals plus or minus, one standard deviation.Plus or
minus one standard deviation encompasses 68% of the population.